Search Results - "Norikane, Takashi"

Predicting pathological response to neoadjuvant chemoradiotherapy in resectable and borderline resectable pancreatic ductal adenocarcinoma: a comparative study of ¹⁸F-FLT and ¹⁸F-FDG PET.

Authors: Norikane, Takashi Fujimoto, Kengo Matsukawa, Hiroyuki et al.

Source: EJNMMI Research. 12/1/2025, Vol. 15 Issue 1, p1-7. 7p.

Torso FDG-PET parameters as prognostic biomarkers for advanced non-small cell lung cancer patients undergoing first-line immunotherapy and chemotherapy.

Authors: Obata, Takafumi Norikane, Takashi Manabe, Yuri et al.

Source: BMC Cancer. 9/30/2025, Vol. 25 Issue 1, p1-9. 9p.

Texture Features of 18 F-Fluorodeoxyglucose Positron Emission Tomography for Predicting Programmed Death-Ligand-1 Levels in Non-Small Cell Lung Cancer.

Authors: Norikane, Takashi Ishimura, Mariko Mitamura, Katsuya et al.

Source: Journal of Clinical Medicine. Mar2024, Vol. 13 Issue 6, p1625. 8p.

Quantitative [^99mTc]Tc-MDP SPECT/CT correlated with [¹⁸F]NaF PET/CT for bone metastases in patients with prostate cancer.

Authors: Tanaka, Kenichi Norikane, Takashi Mitamura, Katsuya et al.

Source: EJNMMI Physics. 12/5/2022, Vol. 9 Issue 1, p1-10. 10p.

Inter-institutional variability in kidney dosimetry during 177Lu-DOTATATE therapy in Japan.

Authors: Miyaji, Noriaki Miwa, Kenta Yamashita, Kosuke et al.

Source: Radiological Physics & Technology; Mar2026, Vol. 19 Issue 1, p165-175, 11p

FDG PET texture indices as imaging biomarkers for epidermal growth factor receptor mutation status in lung adenocarcinoma.

Authors: Ishimura, Mariko Norikane, Takashi Mitamura, Katsuya et al.

Source: Scientific Reports. 4/25/2023, Vol. 13 Issue 1, p1-7. 7p.

Harmonized quantitative bone SPECT/CT parameters for risk assessment of medication-related osteonecrosis of the jaw: multicenter study.

Authors: Kitajima, Kazuhiro Iwabuchi, Yu Inui, Yoshitaka et al.

Source: EJNMMI Research. 3/4/2026, Vol. 16 Issue 1, p1-8. 8p.

Relationship between [¹⁸F]FDG PET/CT and metabolomics in patients with colorectal cancer.

Authors: Imajo, Masashi Norikane, Takashi Yamamoto, Yuka et al.

Source: Metabolomics. Nov2022, Vol. 18 Issue 11, p1-7. 7p.

Combination of whole body [¹⁸F]FDG PET angiography and PET/CT for giant cell arteritis.

Authors: Norikane, Takashi Yamamoto, Yuka Takami, Yasukage et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jan2022, Vol. 49 Issue 2, p779-780. 2p. 1 Diagram.

[¹⁸F] FDG uptake in patients with spondyloarthritis: correlation with serum inflammatory biomarker levels.

Authors: Manabe, Yuri Norikane, Takashi Yamamoto, Yuka et al.

Source: EJNMMI Research. 2/15/2023, Vol. 13 Issue 1, p1-11. 11p.

One-stop shopping ¹⁸F-FDG PET/CT in a patient with vascular type Behçet's disease.

Authors: Norikane, Takashi Yamamoto, Yuka Takami, Yasukage et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2019, Vol. 46 Issue 7, p1578-1580. 3p. 1 Color Photograph, 1 Black and White Photograph.

Risk factors for motion artifacts in fast spin-echo T2-weighted imaging of the prostate magnetic resonance imaging: a retrospective study.

Authors: Kobata, Takuya Yamasaki, Tatsuya Katayama, Hiroki et al.

Source: Radiological Physics & Technology; Jun2025, Vol. 18 Issue 2, p582-588, 7p

Correlation of 4′-[methyl-11C]-thiothymidine PET with Gd-enhanced and FLAIR MRI in patients with newly diagnosed glioma.

Authors: Norikane, Takashi Mitamura, Katsuya Yamamoto, Yuka et al.

Source: EJNMMI Research. 4/30/2021, Vol. 11 Issue 1, p1-7. 7p.

Interim 4′-[methyl-11C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [18F]FDG PET.

Authors: Mitamura, Katsuya Norikane, Takashi Yamamoto, Yuka et al.

Source: EJNMMI Research. 2/10/2021, Vol. 11 Issue 1, p1-8. 8p.

18F-FDG PET/CT in patients with polymyositis/dermatomyositis: correlation with serum muscle enzymes.

Authors: Arai-Okuda, Hanae Norikane, Takashi Yamamoto, Yuka et al.

Source: European Journal of Hybrid Imaging. 8/12/2020, Vol. 4 Issue 1, p1-10. 10p.

Radiation-induced myocardial damage indicated by focal defect on ¹²³I-MIBG SPECT.

Authors: Norikane, Takashi Yamamoto, Yuka Takami, Yasukage et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2019, Vol. 46 Issue 11, p2404-2405. 2p. 1 Diagram.

Harmonization of Quantitative Values in Bone SPECT/CT for Medication-Related Osteonecrosis of the Jaw.

Authors: Kuromori, Issei Daisaki, Hiromitsu Owaki, Yoshiki et al.

Source: Journal of Nuclear Medicine Technology. Dec2025, Vol. 53 Issue 4, p345-352. 8p.

Appearance time of blood in the brain as a possible indicator of oxygen extraction fraction: a feasibility study.

Authors: Murao, Mitsumasa Kudomi, Nobuyuki Mitamura, Katsuya et al.

Source: EJNMMI Research. 10/16/2024, p1-8. 8p.

Comparative evaluation of F-FLT and F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis.

Authors: Norikane, Takashi Yamamoto, Yuka Maeda, Yukito et al.

Source: EJNMMI Research. 8/29/2017, Vol. 7 Issue 1, p1-7. 7p.

FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.

Authors: Kameda, Tomohiro Nakashima, Shusaku Mitamura, Katsuya et al.

Source: Scientific Reports. 9/13/2022, Vol. 12 Issue 1, p1-7. 7p.